Algen Biotechnologies

Using CRISPR to find treatments for cancer and inflammation

Algen is using CRISPR to uncover disease-driving RNA messages to find treatments for cancer, inflammation and diseases with high unmet needs. We are harnessing the power of CRISPR and machine learning to find first-in-class drugs that modulate RNA messages at single-cell resolution. Algen's founders are bioengineer from Jennifer Doudna Lab and biotech commercialization expert, teamed up with experienced pharmaceutical executives.

Category
Analytics
Pricing
freemium
Difficulty
beginner

Y Combinator batch: Winter 2020

Directory records are starting points for research. Check the official website for current features, pricing and availability. A catalog sync is not a hands-on product review.

Official website

Features

  • Team Collaboration

Industries

  • Healthcare